Access Resources
6001 - 6010 of 7616 Results
Title
Year
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein2016RESTRICTEDTitle: A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0125-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0125-0Citation Count: 33
-
RESTRICTEDTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 30
- Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension2016RESTRICTEDTitle: Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotensionJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-016-0665-5Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-016-0665-5Citation Count: 3
-
RESTRICTEDTitle: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 30Issue #: 11Start Page: 3853End Page: 3859Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.201600756rBest OA location URL: https://www.fasebj.org/doi/pdf/10.1096/fj.201600756RCitation Count: 283
- Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker2016RESTRICTEDTitle: Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarkerJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep31391Best OA location URL: https://www.nature.com/articles/srep31391.pdfCitation Count: 31
-
RESTRICTEDTitle: Moving Parkinson care to the homeJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1258End Page: 1262Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26744Best OA location URL: https://europepmc.org/articles/pmc5014631?pdf=renderCitation Count: 106
- Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease2016RESTRICTEDTitle: Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 213Issue #: 9Start Page: 1759End Page: 1778Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1084/jem.20160368Best OA location URL: https://rupress.org/jem/article-pdf/213/9/1759/1134774/jem_20160368.pdfCitation Count: 309
- Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in mice2016RESTRICTEDTitle: Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in miceJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 35Issue #: 18Start Page: 2008End Page: 2025Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.15252/embj.201593585Best OA location URL: https://europepmc.org/articles/pmc5282834?pdf=renderCitation Count: 60
- Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers2016RESTRICTEDTitle: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1201End Page: 1211Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036Best OA location URL: https://europepmc.org/articles/pmc5073817?pdf=renderCitation Count: 50
- Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations2016RESTRICTEDTitle: Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete ObservationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 8Start Page: e0157077End Page: e0157077Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0157077Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157077&type=printableCitation Count: 103